DE60221883D1 - Screeningverfahren für einen auf die zellwand wirkenden arzneistoff - Google Patents

Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Info

Publication number
DE60221883D1
DE60221883D1 DE60221883T DE60221883T DE60221883D1 DE 60221883 D1 DE60221883 D1 DE 60221883D1 DE 60221883 T DE60221883 T DE 60221883T DE 60221883 T DE60221883 T DE 60221883T DE 60221883 D1 DE60221883 D1 DE 60221883D1
Authority
DE
Germany
Prior art keywords
cell wall
reporter protein
targeting site
screening method
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221883T
Other languages
English (en)
Other versions
DE60221883T2 (de
Inventor
Akihiro Kitamura
Ryohei Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of DE60221883D1 publication Critical patent/DE60221883D1/de
Application granted granted Critical
Publication of DE60221883T2 publication Critical patent/DE60221883T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60221883T 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff Expired - Lifetime DE60221883T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001323293 2001-10-22
JP2001323293 2001-10-22
PCT/JP2002/010932 WO2003035898A1 (fr) 2001-10-22 2002-10-22 Methode de criblage d'un medicament agissant sur la paroi cellulaire

Publications (2)

Publication Number Publication Date
DE60221883D1 true DE60221883D1 (de) 2007-09-27
DE60221883T2 DE60221883T2 (de) 2008-04-30

Family

ID=19140207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221883T Expired - Lifetime DE60221883T2 (de) 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Country Status (9)

Country Link
US (1) US7459268B2 (de)
EP (1) EP1445327B1 (de)
JP (1) JP4204471B2 (de)
AT (1) ATE370243T1 (de)
CA (1) CA2464396A1 (de)
DE (1) DE60221883T2 (de)
ES (1) ES2294172T3 (de)
NO (1) NO20042089L (de)
WO (1) WO2003035898A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2294172T3 (es) 2001-10-22 2008-04-01 Daiichi Sankyo Company, Limited Procedimiento para cribar un medicamento que actua sobre la pared celular.
EP1926745A1 (de) * 2005-09-22 2008-06-04 Suntory Limited Genkodierendes zellwand-manoprotein und verwendungen davon
TWI428091B (zh) * 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
WO2020018888A1 (en) 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN115094142B (zh) * 2022-07-19 2024-05-28 中国医学科学院肿瘤医院 用于诊断肺肠型腺癌的甲基化标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU95105899A (ru) 1992-07-08 1997-03-20 Унилевер Н.В. (NL) Способ иммобилизации фермента, полинуклеотид, вектор, химерный блок, низшие эукариоты, способ осуществления ферментативного процесса
JPH0956384A (ja) * 1995-08-25 1997-03-04 Toray Ind Inc 細胞の標識方法
EP0916726A1 (de) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
AU4566699A (en) * 1998-06-25 2000-01-10 Collaborative Group, Ltd., The Beta(1,6)-glucan synthesis and cell wall assembly assay
JP2000102387A (ja) 1998-09-29 2000-04-11 Daicel Chem Ind Ltd 発光蛋白質発現組換えベクター、及びこの組換えベクターにより形質転換された酵母
AU2001252604A1 (en) 2000-05-01 2001-11-12 Daiichi Pharmaceutical Co., Ltd. Method of screening drug acting on cell wall
ES2294172T3 (es) 2001-10-22 2008-04-01 Daiichi Sankyo Company, Limited Procedimiento para cribar un medicamento que actua sobre la pared celular.

Also Published As

Publication number Publication date
ES2294172T3 (es) 2008-04-01
JP4204471B2 (ja) 2009-01-07
US20050069965A1 (en) 2005-03-31
EP1445327A4 (de) 2005-09-14
CA2464396A1 (en) 2003-05-01
ATE370243T1 (de) 2007-09-15
EP1445327A1 (de) 2004-08-11
NO20042089L (no) 2004-05-21
JPWO2003035898A1 (ja) 2005-02-10
WO2003035898A1 (fr) 2003-05-01
DE60221883T2 (de) 2008-04-30
US7459268B2 (en) 2008-12-02
EP1445327B1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
HK1094231A1 (en) Prebiotic effect analysis
MXPA03000226A (es) Diagnosticos tempranos de enfermedades conformacionales.
ATE342377T1 (de) Spezifische detektionsmedien für staphylococcus aureus und identifizierungs- und/oder zaehlmethode unter verwendung besagter detektionsmedien
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
ATE437216T1 (de) Schnellnachweis replizierender zellen
ATE516497T1 (de) Screening für funktionshomologien
EA200970233A1 (ru) Кандидатные агенты против инфекций
FR2878109B1 (fr) Procede d'evaluation de la comptabilite entre des applications et des dispositifs de traitement
ATE335852T1 (de) Happier mapping
DE60221883D1 (de) Screeningverfahren für einen auf die zellwand wirkenden arzneistoff
WO2002066975A3 (en) Tissue-based water quality biosensors for detecting chemical warfare agents
ATE479097T1 (de) Verfahren zur diagnose oder prognostizierung der wesentlichen bakteriellen erreger von atemwegserkrankungen in einem patienten
DE60334923D1 (de) Tät
ATE550664T1 (de) Multiplex-screening auf lysosomale speicherkrankheiten (lsds)
DE602006019628D1 (de) Verfahren zum testen von enzymaktivität in einer histologischen probe
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
WO2005026875A3 (en) System and method for diagnostic analysis of delivery services
DE602004026439D1 (de) Lp-pla2-aktivitätstest mit hohem durchsatz
NO20025217D0 (no) FremgangsmÕte for screening av legemiddel som virker pÕ cellevegg
Hagihara et al. An experimental study about survey response rate Basic study of efficient strategies to raise the participation rate of Mobility Management
ATE251749T1 (de) Verfahren zum nachweis von mastitis
ATE364095T1 (de) Gtp cyclohydrolase ii als ziel für fungizide
ATE550662T1 (de) Diagnose- und behandlungsverfahren sowie dafür geeignete mittel
EA200000500A1 (ru) Способ испытания средства защиты на функционирование
FR2863273B1 (fr) Milieu, dispositif et procede de test de la sensibilite d'un inoculum de champignons a un agent antifongique

Legal Events

Date Code Title Description
8364 No opposition during term of opposition